occurrence of transient ischemic attacks during the treatment period was not reduced by asa treatment , whereas there was a trend suggesting fewer myocardial infarctions in the asa group ( 5.9 % ) than in the placebo group ( 13.7 % ) .
C0027051
myocardial infarctions
C0004057
asa